{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:03:25Z","timestamp":1790827405067,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CSRP170428229183"],"award-info":[{"award-number":["CSRP170428229183"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jmgm.2024.108850","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:41:12Z","timestamp":1724892072000},"page":"108850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Contrasting the effect of hinge region insertions and non-active site mutations on HIV protease-inhibitor interactions: Insights from altered flap dynamics"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-4997","authenticated-orcid":false,"given":"Tshele","family":"Mokhantso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Pandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikechukwu","family":"Achilonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1781-2115","authenticated-orcid":false,"given":"Yasien","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2024.108850_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/aid.1992.8.153","article-title":"The HIV-1 protease as a therapeutic target for AIDS","volume":"8","author":"Debouck","year":"1992","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jmgm.2024.108850_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000002689","article-title":"High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients","author":"Bossard","year":"2021","journal-title":"JAIDS J. Acqu. Immu. Defici. Syndrom."},{"key":"10.1016\/j.jmgm.2024.108850_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jmgm.2024.108850_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jmgm.2024.108850_bib5","first-page":"67","article-title":"HIV-1 drug resistance mutations: an updated framework for the second decade of HAART","volume":"10","author":"Shafer","year":"2008","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jmgm.2024.108850_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/aje\/kwi133","article-title":"Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection","volume":"161","author":"Vlahov","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jmgm.2024.108850_bib7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1110\/ps.0206402","article-title":"Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease","volume":"11","author":"Ohtaka","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2024.108850_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-3156.2007.01984.x","article-title":"Polymorphisms in HIV-1 subtype C proteases and the potential impact on protease inhibitors","volume":"13","author":"Bessong","year":"2008","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jmgm.2024.108850_bib9","doi-asserted-by":"crossref","first-page":"22741","DOI":"10.1074\/jbc.M116.747568","article-title":"Effects of hinge-region natural polymorphisms on human immunodeficiency virus-type 1 protease structure, dynamics, and drug pressure evolution","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2024.108850_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2022.07.033","article-title":"Non-active site mutations in the HIV protease: diminished drug binding affinity is achieved through modulating the hydrophobic sliding mechanism","volume":"217","author":"Sherry","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jmgm.2024.108850_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/genes14020533","article-title":"Understanding drug resistance of wild-type and L38HL insertion mutant of HIV-1 C protease to Saquinavir","volume":"14","author":"Venkatachalam","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.jmgm.2024.108850_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/biom11040489","article-title":"Acquired HIV-1 protease conformational flexibility associated with Lopinavir failure may shape the outcome of Darunavir therapy after antiretroviral therapy switch","volume":"11","author":"Eche","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2024.108850_bib13","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.00726-08","article-title":"Active-site mutations in the South African human immunodeficiency virus type 1 subtype C protease have a significant impact on clinical inhibitor binding: kinetic and thermodynamic study","volume":"82","author":"Mosebi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2024.108850_bib14","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1021\/bi020160i","article-title":"Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes","volume":"41","author":"Velazquez-Campoy","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2024.108850_bib15","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.1021\/bi049459m","article-title":"Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease","volume":"43","author":"Clemente","year":"2004","journal-title":"Biochemistry"},{"issue":"1979","key":"10.1016\/j.jmgm.2024.108850_bib16","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2024.108850_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/bi501088e","article-title":"Defective hydrophobic sliding mechanism and active site expansion in HIV-1 protease drug resistant variant Gly48Thr\/Leu89Met: mechanisms for the loss of Saquinavir binding potency","volume":"54","author":"Goldfarb","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2024.108850_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107931","article-title":"Cantilever-centric mechanism of cooperative non-active site mutations in HIV protease: implications for flap dynamics","volume":"106","author":"Sherry","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2024.108850_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.str.2007.01.006","article-title":"Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease","volume":"15","author":"Foulkes-Murzycki","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2024.108850_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2018.03.006","article-title":"Molecular dynamics and ligand docking of a hinge region variant of South African HIV-1 subtype C protease","volume":"82","author":"Zondagh","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2024.108850_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BCJ20180692","article-title":"Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility","volume":"476","author":"Williams","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmgm.2024.108850_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s10930-023-10132-6","article-title":"HIV protease hinge region insertions at codon 38 affect enzyme kinetics, conformational stability and dynamics","author":"Sheik Ismail","year":"2023","journal-title":"Protein J."},{"key":"10.1016\/j.jmgm.2024.108850_bib23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/14756366.2019.1636234","article-title":"Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D\u2191G\u2191S mutant in the South African HIV-1 subtype C protease","volume":"34","author":"Maseko","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2024.108850_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jmgm.2024.108850_bib25","doi-asserted-by":"crossref","DOI":"10.1063\/1.2434972","article-title":"Explicit symplectic integrators of molecular dynamics algorithms for rigid-body molecules in the canonical, isobaric-isothermal, and related ensembles","volume":"126","author":"Okumura","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2024.108850_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.biophys.27.1.249","article-title":"Inhibitors OF HIV-1 PROTEASE: a major success of structure-assisted drug design","volume":"27","author":"Wlodawer","year":"1998","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.jmgm.2024.108850_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0969-2126(00)00537-2","article-title":"Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance","volume":"8","author":"Scott","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2024.108850_bib28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1110\/ps.03468904","article-title":"HIV-1 protease molecular dynamics of a wild-type and of the V82F\/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs","volume":"13","author":"Perryman","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2024.108850_bib29","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.febslet.2014.06.051","article-title":"Effects of PRE and POST therapy drug\u2010pressure selected mutations on HIV\u20101 protease conformational sampling","volume":"588","author":"Carter","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmgm.2024.108850_bib30","doi-asserted-by":"crossref","first-page":"11956","DOI":"10.1021\/ja504096m","article-title":"Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease","volume":"136","author":"Ragland","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2024.108850_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1097-0134(19990801)36:2<147::AID-PROT2>3.0.CO;2-3","article-title":"The effect of inhibitor binding on the structural stability and cooperativity of the HIV-1 protease","volume":"36","author":"Todd","year":"1999","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2024.108850_bib32","doi-asserted-by":"crossref","first-page":"33231","DOI":"10.1074\/jbc.271.52.33231","article-title":"Human immunodeficiency virus","volume":"271","author":"Maschera","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2024.108850_bib33","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1021\/bi00063a035","article-title":"Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution","volume":"32","author":"York","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2024.108850_bib34","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1021\/bi980784h","article-title":"Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease","volume":"37","author":"Swairjo","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2024.108850_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10930-013-9517-y","article-title":"F99 is critical for dimerization and activation of South African HIV-1 subtype C protease","volume":"32","author":"Naicker","year":"2013","journal-title":"Protein J."},{"issue":"10","key":"10.1016\/j.jmgm.2024.108850_bib36","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/AAC.00574-10","article-title":"HIV-1 protease mutations and protease inhibitor cross-resistance","volume":"54","author":"Rhee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2024.108850_bib37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0969-2126(99)80172-5","article-title":"Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function","volume":"7","author":"Ishima","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2024.108850_bib38","first-page":"1047","article-title":"A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex","author":"Katoh","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2024.108850_bib39","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/prot.22806","article-title":"Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing","volume":"78","author":"Sadiq","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2024.108850_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/genes14020533","article-title":"Understanding drug resistance of wild-type and L38HL insertion mutant of HIV-1 C protease to Saquinavir","volume":"14","author":"Venkatachalam","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.jmgm.2024.108850_bib41","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/acs.jcim.3c00535","article-title":"Evolving mutational buildup in HIV-1 protease shifts conformational dynamics to gain drug resistance","volume":"63","author":"Souffrant","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2024.108850_bib42","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/acs.jctc.7b00601","article-title":"Elucidating the interdependence of drug resistance from combinations of mutations","volume":"13","author":"Ragland","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2024.108850_bib43","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acs.jctc.0c01244","article-title":"Decifering complex mechanisms of resistance and loss of potency through coupled molecular dynamics and machine learning","volume":"17","author":"Leidner","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2024.108850_bib44","first-page":"79","article-title":"Elasticity-associated functionality and inhibition of HIV protease","author":"Sherry","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jmgm.2024.108850_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cbdd.12690","article-title":"Binding free energy calculations of nine-fda approved protease inhibitors against HIV-1 subtype C I36TT containing 100 amino acids per monomer","volume":"87","author":"Lockhat","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2024.108850_bib46","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/ci100200u","article-title":"Computational analysis of HIV-1 protease protein binding pockets","volume":"50","author":"Ko","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2024.108850_bib47","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11224-019-01305-0","article-title":"Molecular alteration in drug susceptibility against subtype B and C-SA HIV-1 proteases: MD study","volume":"30","author":"Halder","year":"2019","journal-title":"Struct. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T14:04:29Z","timestamp":1729173869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326324001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S1093326324001505"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108850","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrasting the effect of hinge region insertions and non-active site mutations on HIV protease-inhibitor interactions: Insights from altered flap dynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108850"}}